Gamal Esmat

Quick Facts

Full Name	Gamal Esmat
Occupation	Physician
Date Of Birth	Jan 3, 1956(1956-01-03)
Age	68
Birthplace	Giza
Country	Egypt
Birth City	Giza Governorate
Horoscope	Capricorn

Gamal Esmat Biography

Gamal Esmat is one of the most popular and richest Physician who was born on January 3, 1956 in Giza, Giza Governorate, Egypt. Esmat is born the 3rd of January 1956, in Giza, Egypt. He is a professor in the department of Hepatology as well as Gastroenterology, Kasr El Ainy Hospital, Faculty of Medicine, Cairo University, Egypt. He is a specialist in viral hepatitis, and all its complications as in the various related techniques and advanced ones like abdominal ultrasonography, and various endoscopic techniques.

In 2013, as direct acting antiviral agents were developed and he was able to establish various clinical trials for HCV genotype 4. Then because of his work in this area and the national committee members, he was able to with members of the national committee to present all new medications for treating viral Hepatitis C genotype 4 at an affordable cost. He devised an innovative method of recruiting patients as well as database processing to facilitate the successful treatment of the Egyptian patients, which can reach approximately 150,000 patients annually, with the introduction of the sofosbuvir-based regimens. In addition, the goal for treatment is 300.000 patients using the all-oral antiviral therapy in the coming years. He has succeeded in introducing various DAAs (as sofosbuvir, simeprevir daclatasvir ledipasvir, paritaprevir) at a very reasonable cost. This was a unique achievement in Egypt because many developed nations have not achieved the obtainable variability nor complete support of the government. Therefore, Prof. Esmat is seeking an important health issue that affects all Egyptian family. His primary goal is to eradicate HCV in Egypt in the next 20 years. The result of his research have saved the lives of millions of patients suffering from chronic HCV. His work was recognized in the WHO as being among their most significant strategies that they have backed. In the latter half of 2015 Professor Esmat made public, at the world’s most famous liver conference, which was hosted through the American Association for Study of Liver Diseases (AASLD), the findings of a massive clinical trial involving an Egyptian chemical compound developed by Pharco’s pharmaceutical company. It was the first major step in tackling the growing hepatitis C epidemic that is sweeping EGYPT. It is an Phase III study that tests Combining Ravidasvir and Sofosbuvir to treat patients suffering from Genotype-4 chronic C virus, which is the largest research of this kind in the world. The trial was announced by Dr. Xu as the Principal Investigator of the study in the 66th Meeting of the American Association for the Study of Liver Diseases conference in San Francisco on November 16 on the 16th of November, 2015. The results of the Phase III study in 300 patients demonstrated that the combination of Ravidasvir 200 mg with Sofosbuvir 400 mg daily for 12 weeks produced continuous virological responses at 12 weeks after treatment rates of 98 percent all-around. The presentation was an Egyptian honour that the presentation was selected as one of just six oral late-breakers. The research suggests that we might be able to treat compensated patients suffering from cirrhotic disease with an excellent response rate in the event that we extend treatment until 16 weeks. No relapses have occurred to date in difficult to treat Interferon-experienced cirrhotic patients treated for 16 weeks.

It was reduced to 10% of its global price. In addition, Prof. Esmat created an institute called the Hepatology Clinical Trials Research Unit (HCTRU) within the National Hepatology and Tropical Medicine Research Institute (NHTMRI) within the Ministry of Health in collaboration with the department of preventive and epidemiology at the University of Maryland School of Medicine in Baltimore, USA. Within this institute, numerous clinical trials were conducted , and approximately 800 Egyptian patients received free treatment and the first study to test the effectiveness of pegylatedinterferon for treating HCV genotype 4. In 2009 Prof. Esmat created Kasr el Ainy viral hepatitis treatment center at Cairo University as a center for referrals to Egyptian patients to prevent, diagnosis and treatment for the chronic HCV along with a distinct institute for research into HCV and HBV, where a variety of innovative international and national clinical trials were conducted. These efforts , as explained by Prof. Esmat served as the basis for the creation of a national guidelines on the treatment of the HCV virus, HBV and hepatocellular carcinoma.

Gamal Esmat Net Worth

Gamal Esmat is one of the richest Physician from Egypt. According to our analysis, Wikipedia, Forbes & Business Insider, Gamal Esmat 's net worth $5 Million. (Last Update: December 11, 2023)

Prof. Esmat’s studies began in 1985 with his involvement in the Schistosomiasis Research Project, when Prof. Esmat was the co-PI of the project which studied the incidence and the epidemiology of schistosomiasis across twelve Egyptian governorates. In this research, Prof. Esmat developed abdominal ultrasonography for the first time to diagnose and grading hepatic Schistosomiasis, which was endorsed from the WHO as a suitable method to determine the presence of the schistosomiasis. This research project had an enormous impact on the management of the schistosomiasis epidemic in Egypt which led to decreasing the prevalence from 40 percent in the 1980s, to 2% by the early 2000s. He contributed in the first textbook “Clinical application of 3D ultrasonography”, by a chapter titled “Three dimensional ultrasonography in hepatogastroenterology”. Additionally, he also contributed in the hepatology text book “Zakim and Boyer’s Hepatology” with a chapter entitled “Parasitic liver disease”.

Gamal Esmat is a distinguished Professor at Endemic Medicine and Hepatogastroenterology Department, Cairo University. He was Vice-President of Cairo University for Graduate Studies and Research. He wrote a amount of scientific papers in the top journals and was particularly focused on hepatitis, liver transplantation, and hepatocellular carcinoma. Since 2001, he has been the director of the Clinical Research Unit, Hepatitis C Project, International Health Division, University of Maryland Baltimore. He is an active part of Numerous Scientific Societies and Organizations and was, in particular, the president of the IASL (International Association to Study Liver) in the years from 2006 to 2008 and was currently the WHO consultant in the treatment of viral Hepatitis.

Height, Weight & Body Measurements

Gamal Esmat height Not available right now. Gamal weight Not Known & body measurements will update soon.

Who is Gamal Esmat Dating?

According to our records, Gamal Esmat is possibily single & has not been previously engaged. As of December 1, 2023, Gamal Esmat’s is not dating anyone.

Relationships Record : We have no records of past relationships for Gamal Esmat. You may help us to build the dating records for Gamal Esmat!

Facts & Trivia

Gamal Ranked on the list of most popular Physician. Also ranked in the elit list of famous people born in Egypt. Gamal Esmat celebrates birthday on January 3 of every year.